Novartis AG Common Stock (NVS)

Other Income/Expenses (Net)

-$1.47B

TTM · Period ending: · USD

NVS logo

NVS Other Income/Expenses (Net)

Latest reported-$1.47B
NVS TTM Other Income/Expenses (Net) ($774.00M → -$1.47B)
High-resolution chart · PNG

NVS other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Novartis AG Common Stock Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
-1,467,294,000
-1,336,977,000
-1,196,977,000
-1,139,000,000
-1,076,000,000
-916,000,000
-904,000,000
-864,000,000
-832,000,000
-792,000,000
-646,000,000
-649,000,000
-678,000,000
-731,000,000
-816,000,000
13,781,000,000
14,017,000,000
14,230,000,000
14,448,000,000
-26,000,000
-25,000,000
-116,000,000
-274,000,000
-253,000,000
-202,000,000
-167,000,000
-146,000,000
-117,000,000
-154,000,000
5,615,000,000
5,686,000,000
5,952,000,000
6,019,000,000
314,000,000
370,000,000
-238,000,000
-312,000,000
-327,000,000
-451,000,000
-620,000,000
-690,000,000
-835,000,000
-843,000,000
108,000,000
966,000,000
1,054,000,000
1,183,000,000
727,000,000
-136,000,000
-98,000,000
-177,000,000
-177,000,000
-274,000,000
-248,000,000
-268,000,000
-273,000,000
-149,000,000
-252,000,000
-225,000,000
-216,000,000
34,000,000
107,000,000
176,000,000
278,000,000
-72,000,000
10,000,000
-60,000,000
-36,000,000
192,000,000
256,000,000
535,000,000
1,334,000,000
781,000,000
634,000,000
537,000,000
-232,000,000
320,000,000
65,000,000
88,000,000
89,000,000
88,000,000
436,000,000
360,000,000
333,000,000
397,000,000
384,000,000
369,000,000
332,000,000
264,000,000
311,000,000
179,000,000
258,000,000
277,000,000
369,000,000
-4,420,000,000
5,260,000,000
-414,000,000
-346,000,000
72,000,000
1,332,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.